Literature DB >> 19845768

Perception of risk of adverse drug reactions: a 3-year follow-up of a cohort of medical students.

Geneviève Durrieu1, C Hurault, C Damase-Michel, J L Montastruc.   

Abstract

Previous studies have pointed out the question of effective training and information to health professionals on pharmacovigilance. The lack of training is known to induce inadequate use of drugs and noncompliance of patients. Pharmacology teaching is performed in the third year of medical studies at the Toulouse Faculty of Medicine. The aim of the study was to investigate the perception of risk of adverse drug reactions (ADRs) by medical students at the end of the one year pharmacology course and two years later, after clinical training period. Sixty-seven students were interviewed in May 2005 and in October 2007. Visual analogue scales were used to define a score of perceived risk of ADRs associated with each drug class (ranking from 0 to 10) before and after pharmacology training. The drug classes evaluated were antibiotics, anticoagulants, antidepressants, aspirin, contraceptive pill, corticosteroids, drugs for arterial hypertension, drugs for diabetes (other than insulin), hypnotics, hypocholesterolaemic drugs, nonsteroidal anti-inflammatory drugs (NSAIDs), postmenopausal hormone replacement therapy and tranquilisers. After pharmacology courses (May 2005), antidepressants were ranked as the most dangerous drugs by medical students [median score (25th-75th centiles): 7.7 (6.3-8.6)], followed by anticoagulants [7.6 (6.6-8.4)] and hypnotics [7.4 (6.1-8.1)]. Contraceptive pills was listed in the last position [median score [4.7 (2.2-6.7)]. Two years later (October 2007), anticoagulants moved into the first position [8.3 (7.3-9.2)], followed by NSAIDs [6.9 (5.0-8.4)] and aspirin [6.8 (5.8-8.4)]. Contraceptive pills remained in the last position. No change was observed for NSAIDs and aspirin, still ranked as dangerous drugs by medical students after clinical training. Values of perceived risk were significantly increased for anticoagulant (+9.2%, P < 0.01) and hypoglycemiant drugs (+27.7%, P < 0.0001). The perceived risk significantly decreased for hypocholesterolaemic (-14.3%, P < 0.0001) and antidepressant drugs (-19.5%, P < 0.0001), but not for hypnotics. The study shows that the perception of risk of ADRs by medical students was modified after clinical training. They were still aware of potentially serious ADRs associated with anticoagulants, aspirin or NSAIDs, but they remained less cautious for drugs such as antidepressants. Additional pharmacology training at the end of medical studies will be useful.

Entities:  

Mesh:

Year:  2009        PMID: 19845768     DOI: 10.1111/j.1472-8206.2009.00783.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  4 in total

1.  What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects.

Authors:  Rike van Eekeren; Leàn Rolfes; Andries S Koster; Lara Magro; Gurumurthy Parthasarathi; Hussain Al Ramimmy; Tim Schutte; Daisuke Tanaka; Eugène van Puijenbroek; Linda Härmark
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

Review 2.  Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature.

Authors:  Michael Reumerman; J Tichelaar; B Piersma; M C Richir; M A van Agtmael
Journal:  Eur J Clin Pharmacol       Date:  2018-06-20       Impact factor: 2.953

3.  Diabetes patient's pharmacovigilance knowledge and risk perception: the influence of being part of a patient organisation.

Authors:  Cristiano Matos; Florence van Hunsel; Rogério Tavares Ribeiro; Dulce Nascimento do Ó; João Filipe Raposo
Journal:  Ther Adv Drug Saf       Date:  2020-09-04

4.  Perception of the risk of adverse reactions to analgesics: differences between medical students and residents.

Authors:  Sandra Castillo-Guzman; Omar González-Santiago; Ismael A Delgado-Leal; Gerardo E Lozano-Luévano; Misael J Reyes-Rodríguez; César V Elizondo-Solis; Teresa A Nava-Obregón; Dionicio Palacios-Ríos
Journal:  PeerJ       Date:  2016-07-28       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.